Colvard David F MD Dabpn

Information may not be reliable

MoodChart | .org

"MoodChart is a research study designed to learn more about how people with bipolar disorder experience their illnesses. It is also designed to make it much easier for people to make Life Charts, which can be valuable clinical tools. A life chart is a particularly useful way of organizing data about your bipolar disorder. The method was developed (by Daniel Lieberman, MD, and Frederick Goodwin, MD) at the National Institute of Health (NIH) in Bethesda, Maryland.

A life chart creates a compact snapshot of your psychiatric history
It presents the data in the form of a graph that makes it easier to understand
Looking at moods, life events, and medication all in one place can reveal patterns that may help with future treatment
Viewing the data as a picture can lead to new insights, and new ways of understanding what can lead to healthy moods, and what can lead to trouble

If you choose to take part in this study, your information will be combined with other volunteers, and this data will be analyzed to help us better understand bipolar disorder. We hope it will be a valuable resource for both researchers and doctors who take care of patients."
www.MoodChart.org

psychTracker Online for depression and bipolar disorder
(The online version of psychTracker lets users track their symptoms and journal in a safe and secure environment for free.)

R. Reid Wilson, Ph.D., Chapel Hill, NC
A free internet self-help site for persons suffering from anxiety, panic attacks, phobias, obsessive-compulsive disorder - OCD, fear of flying and post-traumatic stress disorder - PTSD. Extensive information and skills, plus the latest on helpful medications.

Training Exercises for Controlling Diver Stress & Panic*
Part 1: The Causes and Symptoms of Diver Stress - (reproduced with permission of Tom Griffiths, Ed.D.)
Part 2: The Calming Breath Response (Diaphragmatic Breathing) - (reproduced with permission of Tom Griffiths, Ed.D.)
Part 3: Mental Rehearsal for Controlling Underwater Stress- (reproduced with permission of Tom Griffiths, Ed.D.)
Part 4: Systematic Progressive Relaxation - (reproduced with permission of Tom Griffiths, Ed.D.)
*These exercises are NOT intended to be a substitute for professional treatment. Consult your personal physician or therapist before using them if you have a history of Panic Disorder or Claustrophobia or any other anxiety problems.

www.ptsdalliance.org
The Posttraumatic Stress Disorder (PTSD) Alliance is a group of professional and advocacy organizations that have joined forces to provide educational resources to individuals diagnosed with PTSD and their loved ones; those at risk for developing PTSD; and medical, healthcare and other frontline professionals.

Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression

A. John Rush, M.D., Madhukar H. Trivedi, M.D., Stephen R. Wisniewski, Ph.D., Jonathan W. Stewart, M.D., Andrew A. Nierenberg, M.D., Michael E. Thase, M.D., Louise Ritz, M.B.A., Melanie M. Biggs, Ph.D., Diane Warden, Ph.D., M.B.A., James F. Luther, M.A., Kathy Shores-Wilson, Ph.D., George Niederehe, Ph.D., Maurizio Fava, M.D., for the STAR*D Study Team (NEJM 354: 1231-1242) March 23, 2006

Conclusions After unsuccessful treatment with an SSRI, approximately one in four patients had a remission of symptoms after switching to another antidepressant. Any one of the medications in the study provided a reasonable second-step choice for patients with depression.
(ClinicalTrials.gov number, NCT00021528 [ClinicalTrials.gov] .)

Medication Augmentation after the Failure of SSRIs for Depression

Madhukar H. Trivedi, M.D., Maurizio Fava, M.D., Stephen R. Wisniewski, Ph.D., Michael E. Thase, M.D., Frederick Quitkin, M.D., Diane Warden, Ph.D., M.B.A., Louise Ritz, M.B.A., Andrew A. Nierenberg, M.D., Barry D. Lebowitz, Ph.D., Melanie M. Biggs, Ph.D., James F. Luther, M.A., Kathy Shores-Wilson, Ph.D., A. John Rush, M.D., for the STAR*D Study Team (NEJM 354: 1243-1252) March 23, 2006
Conclusions Augmentation of citalopram with either sustained-release bupropion or buspirone appears to be useful in actual clinical settings. Augmentation with sustained-release bupropion does have certain advantages, including a greater reduction in the number and severity of symptoms and fewer side effects and adverse events.
(ClinicalTrials.gov number, NCT00021528[ClinicalTrials.gov] .)

Disclaimer: The content of this website, and any services contained therein, is not intended to, and does not, provide medical advice, diagnosis, or treatment. Any communication with the physician through this website does not establish a physician-patient relationship.